| Net Cash Provided by (Used in) Operating Activities |
-7.41M |
USD |
-292% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
15.6M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-16.6M |
USD |
-244% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
16.2M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.44M |
USD |
-160% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
29.7M |
USD |
-57% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.59M |
USD |
-0.63% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
| Deferred Tax Assets, Gross |
2.07M |
USD |
-63.9% |
Q4 2023 |
FY 2023 |
| Depreciation |
11M |
USD |
-12.2% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q4 2023 |
FY 2023 |
| Preferred Stock, Shares Issued |
901K |
shares |
-50% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
4.37M |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
15M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
61.2M |
USD |
-0.26% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
901K |
shares |
-50% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
-3.38M |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
2.9M |
USD |
-8.92% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
2 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |